The ASX 200 has bounced back following a $25 billion wipeout on Wednesday triggered by Donald Trump escalating his trade war ...

AI could inject an additional $461 billion into the healthcare sector by 2035, according to Accenture, as it races past the $2.26 trillion mark. This shift isn't just about diagnostics or ...

The latest trading day saw AbbVie (ABBV) settling at $190.58, representing a +2.25% change from its previous close.

After years of post-COVID-19 normalization and the impact of its Kenvue spinoff, Johnson & Johnson’s (NYSE: JNJ) stock price ...

Johnson & Johnson (NYSE:JNJ) reported Q2 2025 earnings on July 16, 2025, posting sales of $23.7 billion (up 4.6%), with adjusted EPS of $2.77 and net earnings of $5.5 billion. Management raised ...

"When I see a bubble forming, I rush in to buy, adding fuel to the fire."— George Soros Bubbles are not just market anomalies ...

Stocks were taken on a wild ride Wednesday as a White House official indicated to CNBC that Trump was moving closer to firing ...

Major U.S. equities indexes were little changed at midday Wednesday after a report on wholesale inflation showed a surprising ...

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) is one of the best oversold NASDAQ stocks to buy now. On June 12, Jefferies ...

If you look at the history of the S&P 500 ( ^GSPC -0.40%) index, dividend stocks have played a significant role in ...

Pfizer (NYSE: PFE) was on top of the world when it came to earnings and stock price performance. This was in early pandemic ...

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the Donald Trump administration's policies. Health care stocks can often be a solid defensive play in an ...